HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Conti Selected Research

Drug Therapy (Chemotherapy)

4/2015ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY.
10/2013Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.
7/2012Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells.
4/2011The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Conti Research Topics

Disease

52Inflammation (Inflammations)
03/2021 - 12/2000
22Neoplasms (Cancer)
11/2019 - 09/2003
19Hypersensitivity (Allergy)
05/2021 - 01/2001
15Infections
03/2021 - 06/2001
12COVID-19
05/2021 - 03/2020
10Asthma (Bronchial Asthma)
01/2018 - 01/2001
8Fever (Fevers)
05/2021 - 01/2007
7Pneumonia (Pneumonitis)
01/2021 - 05/2001
5Thrombosis (Thrombus)
03/2021 - 04/2008
5Atherosclerosis
11/2018 - 03/2001
5Autoimmune Diseases (Autoimmune Disease)
01/2016 - 01/2007
5Sarcoma (Soft Tissue Sarcoma)
04/2015 - 04/2010
4Anaphylaxis (Anaphylactic Shock)
05/2021 - 10/2013
4Pain (Aches)
05/2021 - 10/2012
4Cytokine Release Syndrome
03/2021 - 09/2020
4Obesity
03/2021 - 09/2003
4Virus Diseases (Viral Diseases)
09/2020 - 03/2020
4Rheumatoid Arthritis
03/2020 - 01/2013
4Psoriasis (Pustulosis Palmaris et Plantaris)
11/2018 - 01/2013
4Parasitic Diseases (Parasitic Disease)
10/2009 - 01/2005
4Granuloma
01/2009 - 05/2003
3Edema (Dropsy)
03/2021 - 07/2013
3Fatigue
03/2021 - 02/2011
3Hemorrhage
03/2021 - 05/2020
3Nausea
03/2021 - 10/2013
3Septic Shock (Toxic Shock Syndrome)
11/2020 - 01/2006
3Fibrosis (Cirrhosis)
03/2020 - 10/2018
3Neuroinflammatory Diseases
05/2018 - 07/2013
3Skin Diseases (Skin Disease)
04/2016 - 04/2013
3Mental Disorders (Mental Disorder)
08/2015 - 04/2014
3Neurogenic Inflammation
01/2014 - 01/2009
3Bacterial Infections (Bacterial Infection)
10/2013 - 12/2000
3Lung Neoplasms (Lung Cancer)
10/2007 - 01/2006
2Sinusitis
05/2021 - 07/2018
2Vomiting
03/2021 - 10/2013
2Chronic Disease (Chronic Diseases)
03/2021 - 07/2012
2Cardiovascular Diseases (Cardiovascular Disease)
03/2021 - 10/2014
2Headache (Headaches)
01/2021 - 07/2018
2Cough
01/2021 - 07/2018
2Periodontitis
12/2020 - 04/2008
2Hypotension (Low Blood Pressure)
11/2020 - 09/2020
2Thrombocytopenia (Thrombopenia)
09/2020 - 04/2008
2Severe Acute Respiratory Syndrome
09/2020 - 07/2020

Drug/Important Bio-Agent (IBA)

51CytokinesIBA
03/2021 - 09/2003
22Interleukin-1 (Interleukin 1)IBA
03/2021 - 01/2006
13Interleukin-6 (Interleukin 6)IBA
03/2021 - 05/2003
12ChemokinesIBA
11/2020 - 02/2001
9Interleukin-33IBA
05/2021 - 07/2012
9Chemokine CCL5IBA
10/2016 - 07/2000
8AntibodiesIBA
05/2021 - 07/2007
7Immunoglobulin E (IgE)IBA
05/2021 - 01/2007
7Proteins (Proteins, Gene)FDA Link
05/2021 - 12/2000
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2015 - 05/2003
6VaccinesIBA
05/2021 - 03/2020
6InterleukinsIBA
03/2021 - 01/2006
6NeuropeptidesIBA
04/2016 - 01/2009
5Messenger RNA (mRNA)IBA
05/2021 - 12/2000
5Pharmaceutical PreparationsIBA
03/2020 - 04/2010
5Member 1 Subfamily B ATP Binding Cassette TransporterIBA
04/2015 - 04/2010
5Doxorubicin (Adriamycin)FDA LinkGeneric
04/2015 - 04/2010
4AntioxidantsIBA
05/2021 - 04/2013
4EnzymesIBA
05/2021 - 12/2000
4Arachidonic Acid (Vitamin F)IBA
09/2020 - 10/2014
4Histamine (Histamine Dihydrochloride)FDA Link
09/2020 - 07/2014
4AllergensIBA
07/2017 - 01/2001
4Substance PIBA
04/2016 - 12/2008
4Potassium PermanganateIBA
01/2009 - 05/2003
3AntigensIBA
05/2021 - 01/2016
3Biological ProductsIBA
03/2021 - 01/2013
3FibrinIBA
03/2021 - 05/2020
3Interleukin-18 (Interleukin 18)IBA
03/2021 - 07/2007
3FlavonoidsIBA
03/2021 - 04/2010
3Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
12/2020 - 01/2013
3EicosanoidsIBA
11/2020 - 10/2006
3Histamine Antagonists (Antihistamines)IBA
09/2020 - 01/2001
3Adrenal Cortex Hormones (Corticosteroids)IBA
07/2020 - 10/2007
3SteroidsIBA
03/2020 - 01/2001
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2016 - 06/2001
3CholesterolIBA
07/2013 - 04/2012
3SolutionsIBA
01/2009 - 05/2003
3AluminumIBA
10/2008 - 10/2007
3CC ChemokinesIBA
01/2007 - 07/2000
3CXC ChemokinesIBA
01/2007 - 01/2005
2Epinephrine (Adrenaline)FDA LinkGeneric
05/2021 - 04/2016
2Immunoglobulin G (IgG)IBA
05/2021 - 01/2004
2Toll-Like Receptors (Toll-Like Receptor)IBA
03/2021 - 03/2020
2LuteolinIBA
03/2021 - 10/2013
2Monoclonal AntibodiesIBA
03/2021 - 03/2020
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
11/2020 - 01/2013
2Platelet Activating FactorIBA
09/2020 - 10/2014
2Oxygen (Dioxygen)IBA
03/2020 - 01/2016
2Therapeutic UsesIBA
03/2020 - 10/2018
2CD40 Ligand (CD40L)IBA
03/2020 - 04/2015
2DNA (Deoxyribonucleic Acid)IBA
05/2019 - 04/2007
2Antigen-Antibody Complex (Immune Complex)IBA
05/2019 - 01/2007
2Prostaglandin D2IBA
07/2018 - 10/2006
2Vitamin EFDA LinkGeneric
01/2018 - 01/2016
2Transcription Factors (Transcription Factor)IBA
01/2018 - 07/2012

Therapy/Procedure

16Therapeutics
03/2021 - 03/2001
4Drug Therapy (Chemotherapy)
04/2015 - 04/2011